Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/109021
Title: Novel missense mutation in the phosphatase PP2A catalytic subunit characterised in a solid tumour cell line
Authors: Baldacchino, Shawn
Saliba, Christian
Fenech, Anthony G.
Grech, Godfrey
Keywords: Chronic myeloid leukemia -- Treatment
Protein phosphatase 2
Phosphoprotein phosphatases -- Inhibitors
K562 cells
Chronic myeloid leukemia -- Chemotherapy
Issue Date: 2012
Publisher: University of Malta. Medical School
Citation: Baldacchino, S., Saliba, C., Fenech, A.G., & Grech, G. (2012). Novel missense mutation in the phosphatase PP2A catalytic subunit characterised in a solid tumour cell line. VIII Malta Medical School Conference abstract book, P4.05.
Abstract: Introduction: The protein serine/threonine phosphatase type 2A (pp2a) is a heterotrimer complex composed of a catalytic subunit (pp2aC), the scaffolding A subunit (pp2aA), and the variable B regulatory subunit. The pp2a complex attenuates the phosphorylation of various signals involved in cell survival and proliferation. Missense mutations in the coding sequence of the PPP2CA catalytic subunit were previously described, and studies of the pathological effects require further investigation. Of interest low pp2a activity was described as a potential mechanism of Chronic Myeloid Leukaemia blast crisis, hence the use of the CML cell line, K562, as a model of pp2a studies. Increasing evidence show that decreased pp2a activity is implicated in the progression of multiple tumour types and provides a potential therapeutic target.
URI: https://www.um.edu.mt/library/oar/handle/123456789/109021
ISSN: 18133339
Appears in Collections:Scholarly Works - FacM&SPat



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.